A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year

Released
2026-01-09 12:05
  • health news
  • news
  • web article

Read more on www.cnbc.com

Picture from image.cnbcfm.com

Related items

Published by

CNBC

In one list